Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel approach to screen for Barrett's Esophagus (BE) and Esophageal Carcinoma (EAC) in rural primary care clinic settings in Oregon.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility of the use of a SECD: Number of providers who indicate likelihood of using SECD
Timeframe: 8 months
Feasibility of the use of SECD: Number of providers who indicate willingness to be trained and train clinic staff
Timeframe: 8 months
Feasibility of the use of SECD: Number of referrals
Timeframe: 8 months
Feasibility of the use of SECD: Number enrolled
Timeframe: 8 months
Patient acceptability: Number of interested patients who schedule an appointment to be screened
Timeframe: 8 months
Patient acceptability: Number of patients who come to their appointments
Timeframe: 8 months
Patient acceptability: Number of patients interested in being screened via SECD at other care centers
Timeframe: 8 months